SIOUX FALLS, S.D. (KELO) — Here are this morning’s top stories for KELOLAND On the Go. General Marty Jackley is calling this week stabbings involving 6 inmates of the South Dakota State penitentiary ...
Pulse Nigeria on MSN
Influencer Fatigue Is Here, and I Am Not Buying It Anymore
Nigerians are tired of over-polished influencer ads. Discover why influence fatigue is rising, and what real authenticity now ...
Hosted on MSN
Why Did The Flash Movie Fail? #shorts
#FailedFranchises #SuperheroMovies #DCU #MCU #GreenLantern #TheAmazingSpiderMan #Sonyverse #BlackAdam #TheFlash #Bloodshot #Eternals #Fant4stic #SuicideSquad #ComicBookMovies #SuperheroCinema ...
Hosted on MSN
Motorsports Fails
Get ready for a wild ride with this hilarious compilation of motorsports fails! From hilarious wipeouts to unexpected flips, this compilation has it all. Missouri mom shot, stabbed 16-year-old son to ...
The October 2025 crypto crash wiped out nearly $19 billion in 24 hours after Donald Trump’s tariff escalation on China.
One common refrain you'll hear from European fans on Ryder Cup week is that U.S. fans don't know how to banter. They aren't creative with their chants and chirps. That's why things tend to take an ...
It’s that time again. The weekend is over, and it’s time to catch up on the latest news. Here’s a quick roundup of the top stories that you might have missed. Lucid Group (NASDAQ: LCID) has seen a ...
Strong US economic data and rising gold prices shift investor focus away from Bitcoin's upside. Regulatory uncertainty and vague US Strategic Bitcoin Reserve plans keep BTC price down despite macro ...
A skydiver plummeted 11,000 feet to the ground after both of his parachutes failed, fracturing his pelvis, but miraculously survived the fall over the Nevada desert. Mitchell Deakin, 25, who had flown ...
Sept 24 (Reuters) - Harmony Biosciences (HRMY.O), opens new tab said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its ...
A phase 2b trial of Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) drug candidate has missed its primary endpoint. But, with other analyses generating signs of efficacy, the biotech made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback